A

바이오비쥬

489460KOSDAQ기타 화학제품 제조업

70.3 / 100

Reference Date: 2026-07-24

Financial Score22.0 / 40
News Sentiment21.3 / 25
Momentum15.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Surged 56.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

BioViju is a global export-focused company specializing in the research, development, and manufacturing of hyaluronic acid (HA)-based skin boosters and fillers, utilizing cross-linking and LNP technologies to ensure product safety. With its own production facility and ISO certification, the company is expanding OEM and general distribution, aiming to secure growth momentum through the expansion of HA filler approvals both domestically and internationally.

Number of Employees

51people

Average Salary

49.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
29.09Industry Average 16.671.5Point

1.7x industry avg (risky)

PBR
2.10Industry Average 1.061.0Point

2.0x industry avg (risky)

ROE
8.94Industry Average 4.555.5Point

2.0x industry avg (good)

Debt Ratio
0.31Industry Average 8.138.0Point

Half of industry avg (excellent)

Trend 6.0 / 10 points
Revenue Growth Rate
1.5 / 3

Operating Profit Growth Rate
1.5 / 3

ROE Trend
3.0 / 4

Detailed News Sentiment

7 totalPositive 7Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position3.0Point

52w lower range (20%)

Current 8,670Won52-week high 20,70052-week low 5,530
1-month return6.0Point

1m +56.78% (strong rise)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 1Neutral 1Negative 0
  • Neutral주식소각결정2026-07-02
  • Positive자기주식취득결과보고서2026-07-01